Answers are grounded in this paper and cite their sources.
This letter to the editor questions the data consistency and imputation methods of a prior study that identified ESVI as the strongest indicator of survival in ischaemic cardiomyopathy.
To the Editor Prior et al. 1 report on survival prediction in patients with ischaemic cardiomyopathy following surgical intervention and found that end-systolic volume (ESV) index (I) is the strongest indicator of survival. Their findings are partly based on an imputation procedure which is reported to have not affected the outcomes. We have no reason to doubt this statement, but we are left with three major issues: 1. Some inconsistencies require clarification. In figure 1, the ESVI range is limited to 150, while …
No takes yet. Share an insight, caveat, or question.
Kerkhof et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: